NCT02182349View on ClinicalTrials.gov

Metabolism and Pharmacokinetics of Oral Solution of [14C]-BI 201335 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2009

Conditions
Healthy
Interventions
DRUG

BI 201335 NA soft gelatin capsule

DRUG

[14C]-BI 201335 NA radiolabelled drug

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY